MedTrace Logo

Prospera Test Evaluation in Cardiac Transplant (ProTECT)

NCT05205551 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 411

Last updated 2025-05-22

No results posted yet for this study

Summary

The ProTECT registry is an observational longitudinal, multi-center study observing patients undergoing heart transplant for whom Prospera testing is part of routine clinical care, who are enrolled within 60 days of heart transplantation.

Conditions

  • Heart Transplant Rejection

Sponsors & Collaborators

  • Natera, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Olymbios, MD · Natera, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2026-10-31
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05205551 on ClinicalTrials.gov